Open AccessJournal Article
Diffuse crescentic glomerulonephritis in bacterial endocarditis (A case report)
About:
This article is published in Zahedan Journal of Research in Medical Sciences.The article was published on 2009-04-01 and is currently open access. It has received 0 citations till now.read more
References
More filters
Journal ArticleDOI
Proteinase-3-antineutrophil cytoplasmic antibody (PR3-ANCA) positive crescentic glomerulonephritis in a patient with Down's syndrome and infectious endocarditis.
Journal ArticleDOI
Diffuse crescentic glomerulonephritis in bacterial endocarditis
Sujatha Kannan,Tej K. Mattoo +1 more
TL;DR: A 24-year-old male patient with endocarditis due to Capnocytophagia species, a gram-negative facultative anaerobic bacillus, which normally inhabits the oral cavity is reported.
Journal ArticleDOI
Successful recovery of infective endocarditis-induced rapidly progressive glomerulonephritis by steroid therapy combined with antibiotics: a case report
TL;DR: It is suggested that the patients with rapidly progressive glomerulonephritis associated with infective endocarditis might be treated with a short-term and low dose of corticosteroid successfully.
Journal ArticleDOI
PR3-ANCA-positive crescentic necrotizing glomerulonephritis accompanied by isolated pulmonic valve infective endocarditis, with reference to previous reports of renal pathology.
Michio Fukuda,M Motokawa,Takeshi Usami,Oikawa T,Kunio Morozumi,Atsuhiro Yoshida,Genjiro Kimura +6 more
TL;DR: This report is the first to document renal pathology in a patient with isolated pulmonic valve IE and PR3-ANCA and show a change in renal biopsy findings in response to treatment, and further studies are needed to clarify the prevalence of pauci-immune GN in ANCA-positive IE patients.
Journal ArticleDOI
An unusual endocarditis-induced crescentic glomerulonephritis treated by plasmapheresis.
TL;DR: This case is an original type III rapidly progressive glomerulonephritis, since ANCA were repeatedly found negative, and plasmapheresis introduced as the third-line therapy, significantly improved renal function.